Connect with us

Business

Jury in Lindsay Clancy Murder Trial Ends the Week Without a Verdict After Asking to See Key Evidence

Published

on

Lindsay Clancy Trial Cut Short as Judge Cites 'Unforeseen Circumstance,'

Mass. — Jurors in the murder trial of Lindsay Clancy, the Massachusetts mother accused of killing her three young children in 2023, ended their second day of deliberations Friday without reaching a verdict and will return Monday morning to continue weighing the case.

The 12-person jury, made up of nine women and three men, has now deliberated for roughly 10 hours over two days, spending about three and a half hours Thursday and roughly six and a half to seven hours Friday, according to the Boston Globe and CNN. Judge William F. Sullivan told jurors, “It’s been a long day for everybody,” before sending them home for the weekend, with deliberations set to resume Monday at 9 a.m.

Clancy, 36, a former labor and delivery nurse, has pleaded not guilty to three counts of murder in the deaths of her children, Cora, 5; Dawson, 3; and Callan, 8 months. Sullivan has instructed the jury that it may return verdicts of first-degree murder, second-degree murder or manslaughter on each of three separate verdict slips, one for each child. Both the prosecution and the defense agree Clancy strangled her children with exercise resistance bands and then attempted suicide at the family’s home in Duxbury on Jan. 24, 2023. The central question for jurors is not what happened, but whether Clancy was “criminally responsible” for her actions, a legal standard requiring that she understood the wrongfulness of what she was doing and was able to control her behavior in accordance with the law.

Prosecutors called more than 70 witnesses over five weeks of testimony, arguing Clancy “acted intentionally, rationally and swiftly” when she killed her children and that she retained the ability to distinguish right from wrong. In her closing argument, Assistant District Attorney Jennifer Sprague told jurors, “I’m not saying she was happy about it. I’m saying, it was what she had to do to end her misery. But it was a choice. It was a choice.” Prosecutors pointed to evidence that Clancy sent her husband out to run errands before the killings and that she asked for an attorney upon waking in the hospital, arguing those actions reflected calculated, rational behavior rather than a break from reality.

Advertisement

Clancy’s defense, which called 10 witnesses, argued she suffered from postpartum psychosis and was not criminally responsible for her actions. Defense attorney Kevin Reddington told jurors in closing arguments that Clancy’s collapse came “because of the damn medicine and the lousy medical care that she got,” pointing to the more than a dozen psychiatric medications she had been prescribed in the months before the killings to treat depression, anxiety, insomnia and suicidal thoughts. Clancy did not testify during the trial. She remains partially paralyzed as a result of her suicide attempt and has been held at a state hospital in Tewksbury since 2023.

Testimony from Clancy’s former husband, Patrick Clancy, traced her mental health decline back to September 2022, as she prepared to return to work following parental leave. “She just had a really hard time being separated from them,” he testified, according to CNN. Her condition worsened in the following months, particularly after she began taking the antidepressant Zoloft in October 2022, and she checked herself into a hospital twice, once in December and again over the New Year’s holiday. Clancy wrote in a note on her phone at the time, “Medication stole my motherhood and my life,” Patrick Clancy testified. Doctors who treated her before the killings said she did not display a suicide plan, thoughts of harming others or signs of psychosis, and her psychiatrist testified that Clancy told her the day before the killings that she was “doing all right.”

Competing psychiatric experts offered sharply different assessments of Clancy’s mental state at the time of the killings. Dr. Phillip Resnick, a forensic psychiatrist who testified for the defense, said Clancy was “frankly psychotic” during the killings and described an auditory hallucination she reported experiencing. “Not only did she hear a command, but she felt that her body was taken over by an external force where she was in a dream state and did not have control of her own body,” Resnick testified. “It was almost like she was a puppet and someone else was pulling the strings.” Dr. Kirk Heilbrun, a psychologist who testified for the prosecution, disagreed, saying Clancy understood right from wrong and was in control of her actions, while expressing skepticism that she had ever reported hearing a voice before or after the killings. Both experts agreed, however, that Clancy’s actions were rooted in a distorted sense of love and protection toward her children rather than malice.

During deliberations Friday, jurors asked to review physical evidence including Clancy’s prescription pill bottles and the knife she used during her suicide attempt, according to Reddington. Sullivan did not publicly disclose the jury’s specific question, discussing it instead with attorneys during a private sidebar conference.

Advertisement

The trial has drawn national attention to questions surrounding maternal mental health, and supporters wearing pink gathered outside the courthouse in Plymouth last week in a show of solidarity with Clancy. If the jury cannot reach a unanimous verdict, Sullivan could declare a mistrial. If convicted of murder, Clancy faces a sentence of life in prison. If jurors find her not guilty by reason of lack of criminal responsibility, prosecutors have said they may petition the court to have her committed to a psychiatric facility rather than released.

This case involves serious mental health and suicide-related content covered here for its factual, legal significance; readers who may be personally affected by similar issues are encouraged to seek support, including from a mental health professional or a crisis helpline.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Microsoft Among 14 Dividend Growth Companies To Annual Dividend Increases In September

Published

on

Microsoft Among 14 Dividend Growth Companies To Annual Dividend Increases In September

This article was written by

I’m an individual investor looking to grow my wealth over the long term. I’ve tried many different styles of investing over the last 25 years and have found that buying dividend growth stocks and reinvesting the dividends is one of the easiest ways to grow wealth over the long term. Over the years, I’ve owned stocks, options, ETFs, treasury notes, and mutual funds. I operate a blog, HarvestingDividends.com, that provides information on the S&P Dividend Aristocrats and other dividend growth stocks.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I may take positions in any of the stocks mentioned in this article in the near future.

Advertisement

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Continue Reading

Business

Gabelli OEF Growth Portfolio Managers Q2 2026 Insights

Published

on

Gabelli OEF Growth Portfolio Managers Q2 2026 Insights

Gabelli OEF Growth Portfolio Managers Q2 2026 Insights

Continue Reading

Business

Why My 3 Worst Picks Beat The S&P 500 In Retirement

Published

on

Why My 3 Worst Picks Beat The S&P 500 In Retirement

Why My 3 Worst Picks Beat The S&P 500 In Retirement

Continue Reading

Business

Aon close to acquiring USI Insurance from KKR in $17 billion deal, WSJ reports

Published

on


Aon close to acquiring USI Insurance from KKR in $17 billion deal, WSJ reports

Continue Reading

Business

TransDigm Group: A Premium Option For Private-Equity-Like Exposure

Published

on

TransDigm Group: A Premium Option For Private-Equity-Like Exposure

TransDigm Group: A Premium Option For Private-Equity-Like Exposure

Continue Reading

Business

Exclusive | Aon Nears Roughly $17 Billion Deal for Insurance Brokerage USI

Published

on

Exclusive | Aon Nears Roughly $17 Billion Deal for Insurance Brokerage USI

Aon

AON

1.67%

Advertisement

increase; up pointing triangle is near an agreement to buy insurance brokerage USI Insurance from private-equity firm KKR KKR -0.59%

decrease; down pointing triangle for roughly $17 billion, including debt, according to people familiar with the matter.

A deal could be announced as soon as Monday, the people said, assuming it comes together.

Advertisement

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

NVDW: Collect High-Yield Income From Nvidia Swaps

Published

on

NVDW: Collect High-Yield Income From Nvidia Swaps

This article was written by

Now retired, I am an income-oriented investor seeking high yield income to support my lifestyle in retirement.I became deeply interested in the stock market beginning in late 2007 (bad timing for me but worse for my uncle) when I received an unexpected inheritance. Since that time I have done considerable research and vowed to make smarter long-term investing decisions after suffering through the Great Recession with minimal losses to my inherited portfolio, after firing my financial advisor.I look for mostly dividend paying income stocks and funds (BDCs, REITs, CEFs, ETFs) that offer high yield income to increase my retirement income beyond my pension and Social Security. I also enjoy reading investment/financial and business information and following trends in technology and markets. The human psychology of markets is as fascinating and inscrutable to me as the financial side. I am not a financial advisor so please do your own due diligence before making any buy or sell decisions.“The race is not always to the swift, nor the battle to the strong, but that’s the way to bet.” Damon Runyon

Analyst’s Disclosure: I/we have a beneficial long position in the shares of NVDW either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Hoegh LNG Partners: A Well-Covered 10.7% Preferred Dividend Yield (OTCMKTS:HMLPF)

Published

on

Strait Of Hormuz: Buy The Fear Before This Waterway Clears

This article was written by

The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks.
He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital gains and dividend income for continuous cash flow. Features include: two model portfolios – the European Small Cap Ideas portfolio and the European REIT Portfolio, weekly updates, educational content to learn more about the European investing opportunities, and an active chat room to discuss the latest developments of the portfolio holdings. Learn more.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of HMLPF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Fortrea Holdings: The Turnaround Is Showing Up In Earnings Before Revenue

Published

on

Fortrea Holdings: The Turnaround Is Showing Up In Earnings Before Revenue

Fortrea Holdings: The Turnaround Is Showing Up In Earnings Before Revenue

Continue Reading

Business

Dell Q2: $51.3 Billion In Backlog; Now Show Me The Profits

Published

on

Dell Q2: $51.3 Billion In Backlog; Now Show Me The Profits

Dell Q2: $51.3 Billion In Backlog; Now Show Me The Profits

Continue Reading

Trending

Copyright © 2025